Alpelisib blocks the PI3K enzyme. It’s mainly used for specific cancers, like those that test positive for HR /HER2 status or have PIK3CA mutations. What Alpelisib does is mess up that whole PI3K message-passing system.
The tablet forms are available in strengths of 50 mg, 200 mg, and 300 mg, with the recommended dose being 300 mg taken once daily, preferably with food. These tablets come in packets that have 28 of ’em.
Reviews
There are no reviews yet.